Medtronic Bets Nearly Half A Billion Dollars On Transcatheter Mitral Valve Market

Earlier this week, medical devices manufacturer Medtronic entered into an agreement to purchase Twelve Inc., a medical device startup focused on the development of a transcatheter mitral valve replacement, for $458 million. The acquisition is a bet on the Transcatheter Mitral Valve Replacement market, which is currently non-existent since no such devices have been approved so far. Medtronic's latest acquisition follows similar acquisitions by rivals Abbott Laboratories and Edwards Lifesciences i...